|
1
|
Bond-Smith G, Banga N, Hammond TM and
Imber CJ: Pancreatic adenocarcinoma. BMJ. 344:e24762012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Casas-Grajales S and Muriel P:
Antioxidants in liver health. World J Gastrointest Pharmacol Ther.
6:59–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He Y, Yue Y, Zheng X, Zhang K, Chen S and
Du Z: Curcumin, inflammation, and chronic diseases: How are they
linked? Molecules. 20:9183–9213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shanmugam MK, Rane G, Kanchi MM, Arfuso F,
Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP and Sethi G:
The multifaceted role of curcumin in cancer prevention and
treatment. Molecules. 20:2728–2769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Z, Li C, Xi H, Gao Y and Xu D:
Curcumin induces apoptosis in pancreatic cancer cells through the
induction of forkhead box O1 and inhibition of the PI3K/Akt
pathway. Mol Med Rep. 12:5415–5422. 2015.PubMed/NCBI
|
|
7
|
Bimonte S, Barbieri A, Palma G, Luciano A,
Rea D and Arra C: Curcumin inhibits tumor growth and angiogenesis
in an orthotopic mouse model of human pancreatic cancer. Biomed Res
Int. 2013:8104232013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Youns M and Fathy GM: Upregulation of
extrinsic apoptotic pathway in curcumin-mediated antiproliferative
effect on human pancreatic carcinogenesis. J Cell Biochem.
114:2654–2665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shakibaei M, Mobasheri A, Lueders C, Busch
F, Shayan P and Goel A: Curcumin enhances the effect of
chemotherapy against colorectal cancer cells by inhibition of NF-κB
and Src protein kinase signaling pathways. PLoS One. 8:e572182013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
James MI, Iwuji C, Irving G, Karmokar A,
Higgins JA, Griffin-Teal N, Thomas A, Greaves P, Cai H, Patel SR,
et al: Curcumin inhibits cancer stem cell phenotypes in ex vivo
models of colorectal liver metastases, and is clinically safe and
tolerable in combination with FOLFOX chemotherapy. Cancer Lett.
364:135–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang BL, Shen YM, Zhang QW, Li YL, Luo M,
Liu Z, Li Y, Qian ZY, Gao X and Shi HS: Codelivery of curcumin and
doxorubicin by MPEG-PCL results in improved efficacy of
systemically administered chemotherapy in mice with lung cancer.
Int J Nanomedicine. 8:3521–3531. 2013.PubMed/NCBI
|
|
12
|
Kasi PD, Tamilselvam R, Skalicka-Woźniak
K, Nabavi SF, Daglia M, Bishayee A, Pazoki-Toroudi H and Nabavi SM:
Molecular targets of curcumin for cancer therapy: An updated
review. Tumour Biol. 37:13017–13028. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shehzad A and Lee YS: Molecular mechanisms
of curcumin action: Signal transduction. Biofactors. 39:27–36.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sharma P and Sharma R: miRNA-mRNA
crosstalk in esophageal cancer: From diagnosis to therapy. Crit Rev
Oncol Hematol. 96:449–462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Orellana EA and Kasinski AL: MicroRNAs in
cancer: A historical perspective on the path from discovery to
therapy. Cancers (Basel). 7:1388–1405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chitkara D, Mittal A and Mahato RI: miRNAs
in pancreatic cancer: Therapeutic potential, delivery challenges
and strategies. Adv Drug Deliv Rev. 81:34–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gayral M, Jo S, Hanoun N, Vignolle-Vidoni
A, Lulka H, Delpu Y, Meulle A, Dufresne M, Humeau M, du Rieu M
Chalret, et al: MicroRNAs as emerging biomarkers and therapeutic
targets for pancreatic cancer. World J Gastroenterol.
20:11199–11209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Khan S, Ansarullah, Kumar D, Jaggi M and
Chauhan SC: Targeting microRNAs in pancreatic cancer: Microplayers
in the big game. Cancer Res. 73:6541–6547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tormo E, Pineda B, Serna E, Guijarro A,
Ribas G, Fores J, Chirivella E, Climent J, Lluch A and Eroles P:
MicroRNA profile in response to Doxorubicin treatment in breast
cancer. J Cell Biochem. 116:2061–2073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hou N, Han J, Li J, Liu Y, Qin Y, Ni L,
Song T and Huang C: MicroRNA profiling in human colon cancer cells
during 5-fluorouracil-induced autophagy. PLoS One. 9:e1147792014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma J, Fang B, Zeng F, Pang H, Zhang J, Shi
Y, Wu X, Cheng L, Ma C, Xia J and Wang Z: Curcumin inhibits cell
growth and invasion through up-regulation of miR-7 in pancreatic
cancer cells. Toxicol Lett. 231:82–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun M, Estrov Z, Ji Y, Coombes KR, Harris
DH and Kurzrock R: Curcumin (diferuloylmethane) alters the
expression profiles of microRNAs in human pancreatic cancer cells.
Mol Cancer Ther. 7:464–473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang D, Qiu S, Ge R, He L, Li M, Li Y and
Peng Y: miR-340 suppresses glioblastoma multiforme. Oncotarget.
6:9257–9270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li X, Gong X, Chen J, Zhang J, Sun J and
Guo M: miR-340 inhibits glioblastoma cell proliferation by
suppressing CDK6, cyclin-D1 and cyclin-D2. Biochem Biophys Res
Commun. 460:670–677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fernandez S, Risolino M, Mandia N, Talotta
F, Soini Y, Incoronato M, Condorelli G, Banfi S and Verde P:
miR-340 inhibits tumor cell proliferation and induces apoptosis by
targeting multiple negative regulators of p27 in non-small cell
lung cancer. Oncogene. 34:3240–3250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Strong AM Poenitzsch, Setaluri V and
Spiegelman VS: MicroRNA-340 as a modulator of RAS-RAF-MAPK
signaling in melanoma. Arch Biochem Biophys. 563:118–124. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J,
Zhao JJ, Mao SS, Zhang GH, Xu XC and Zhang N: miR-340 inhibition of
breast cancer cell migration and invasion through targeting of
oncoprotein c-Met. Cancer. 117:2842–2852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Teiten MH, Dicato M and Diederich M:
Curcumin as a regulator of epigenetic events. Mol Nutr Food Res.
57:1619–1629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye M and Zhang J and Zhang J, Miao Q, Yao
L and Zhang J: Curcumin promotes apoptosis by activating the
p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.
Cancer Lett. 357:196–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hünten S, Kaller M, Drepper F, Oeljeklaus
S, Bonfert T, Erhard F, Dueck A, Eichner N, Friedel CC, Meister G,
et al: p53-regulated networks of protein, mRNA, miRNA, and lncRNA
expression revealed by integrated pulsed stable isotope labeling
with amino acids in cell culture (pSILAC) and next generation
sequencing (NGS) analyses. Mol Cell Proteomics. 14:2609–2629. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Deveraux QL and Reed JC: IAP family
proteins-suppressors of apoptosis. Genes Dev. 13:239–252. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wilkinson JC, Cepero E, Boise LH and
Duckett CS: Upstream regulatory role for XIAP in receptor-mediated
apoptosis. Mol Cell Biol. 24:7003–7014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Srivastava AK, Singh PK, Singh D, Dalela
D, Rath SK, Goel MM and Bhatt ML: Evaluation of urinary XIAP as a
diagnostic biomarker of carcinoma of urinary bladder. Tumour Biol.
35:8243–8248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu YC, Liu Q, Dai JQ, Yin ZQ, Tang L, Ma
Y, Lin XL and Wang HX: Tissue microarray analysis of X-linked
inhibitor of apoptosis (XIAP) expression in breast cancer patients.
Med Oncol. 31:7642014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baykara M, Yaman M, Buyukberber S, Tufan
G, Demirci U, Benekli M, Coskun U, Ozet A and Bagriacik E Umit:
Clinical and prognostic importance of XIAP and USP8 in advanced
stages of non-small cell lung cancer. J BUON. 18:921–927.
2013.PubMed/NCBI
|
